DuLac Farmaceutici, an Italian wellness company with over 30 years of pharmaceutical industry experience, today announced plans to expand its presence across the United States following continued growth through its Amazon U.S. storefront. The company's expansion strategy targets broader retail, e-commerce, wellness, and recovery-focused distribution channels in the coming months.
Founded on pharmaceutical heritage, DuLac Farmaceutici has built a reputation in Europe for combining traditional botanical ingredients with advanced manufacturing technologies and pharmacy-first production standards. The company's growing U.S. presence reflects increasing consumer demand for wellness and recovery products developed with pharmaceutical-grade precision, clean-label formulations, and ingredient traceability.
"At DuLac, our mission has always been to develop innovative and effective wellness solutions rooted in both science and nature," said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. "We are excited to continue expanding our presence in the United States and introduce more consumers to products developed through decades of Italian pharmaceutical expertise, advanced research, and high-quality manufacturing standards."
DuLac's portfolio includes recovery-focused dermocosmetic products, wellness solutions, and circulation-support formulations designed for active lifestyles, everyday comfort, and wellness-conscious consumers. Key products include the Arnica Gel 98% collection, Arnica Gel 98% Formula Complex recovery products, and vascular and microcirculation wellness solutions such as Diosmin 500 and Dinaven.
For its Arnica Gel 98% formulations, DuLac utilizes a vertically integrated "seed-to-shelf" production model to support phytocomplex consistency, traceability, and quality control across cultivation, extraction, formulation, and manufacturing. The company employs advanced technologies including supercritical CO₂ extraction and controlled-environment cultivation systems to preserve botanical integrity.
DuLac recently partnered with a state-of-the-art 2,500-square-meter research and manufacturing hub in Italy that combines AI-assisted formulation technology with pharmaceutical-grade production standards. The facility operates under GMP, ISO 22716, and ISO 9001 quality frameworks, supporting the company's international expansion.
"Our goal is not simply to sell wellness products, but to elevate standards across the category," added Bollani. "By combining pharmaceutical expertise, modern innovation, and carefully selected natural ingredients, we are building solutions designed around real consumer wellness needs."
The expansion matters because it brings pharmaceutical-grade, clean-label wellness products to a broader U.S. audience, potentially raising standards in the dermocosmetic and recovery product market. The vertical integration and advanced extraction technologies DuLac employs could influence industry practices around ingredient traceability and quality control. For consumers, the expansion means increased access to products developed with Italian pharmaceutical expertise and rigorous quality standards.
Consumers can currently explore DuLac Farmaceutici products through the company's official Amazon storefront.
